| Market Capitalization (Millions $) |
16 |
| Shares
Outstanding (Millions) |
14 |
| Employees |
10 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-9 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Cocrystal Pharma Inc. is a biopharmaceutical company located in Bothell, Washington. It was founded in 2014, and its mission is to develop novel antiviral therapeutics for the treatment of serious and life-threatening diseases. The company's focus is on developing products that target the replication of viruses inside the human body.
Cocrystal Pharma has developed a unique platform technology that enables the discovery of new drugs targeting viral replication, with the potential to transform the treatment of viral diseases. The company has a strong patent portfolio covering the composition of matter, formulation, and therapeutic use of its antiviral compounds.
Cocrystal Pharma's lead drug candidate is CC-31244, which is being developed as a treatment for influenza. The company is also developing other antiviral compounds, including CC-42344 for the treatment of hepatitis C and CC-82545 for the treatment of COVID-19.
In addition to its own drug development programs, Cocrystal Pharma has entered into collaborations with several pharmaceutical companies to leverage its platform technology for the discovery and development of new drugs. These collaborations include partnerships with Merck, Bristol-Myers Squibb, and Adimab.
The company's management team includes seasoned professionals with extensive experience in drug development and finance. Its Board of Directors includes prominent figures in the biotech and pharmaceutical industries, including Dr. Phillip Frost and Dr. Gary Wilcox.
Overall, Cocrystal Pharma is an innovative biopharmaceutical company focused on developing a new generation of antiviral drugs for the treatment of serious diseases. Its pipeline of drug candidates, strong patent portfolio, and experienced management team make it a promising player in the biotech industry.
Company Address: 19805 North Creek Parkway Bothell 98011 WA
Company Phone Number: 262-7123 Stock Exchange / Ticker: NASDAQ COCP
|
0.07% 
100 %